Display options
Share it on

Ann Clin Transl Neurol. 2016 Aug 28;3(10):812-818. doi: 10.1002/acn3.338. eCollection 2016 Oct.

Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies.

Annals of clinical and translational neurology

Graham Fairfoul, Lynne I McGuire, Suvankar Pal, James W Ironside, Juliane Neumann, Sharon Christie, Catherine Joachim, Margaret Esiri, Samuel G Evetts, Michal Rolinski, Fahd Baig, Claudio Ruffmann, Richard Wade-Martins, Michele T M Hu, Laura Parkkinen, Alison J E Green

Affiliations

  1. The National CJD Research & Surveillance Unit Western General Hospital University of Edinburgh Edinburgh EH4 2XU United Kingdom.
  2. The National CJD Research & Surveillance Unit Western General Hospital University of Edinburgh Edinburgh EH4 2XU United Kingdom; Centre for Clinical Brain Sciences Western General Hospital Edinburgh EH4 2XU United Kingdom.
  3. Oxford Parkinson's Disease Centre Nuffield Department of Clinical Neurosciences University of Oxford John Radcliffe Hospital Level 6 West Wing Oxford OX3 9DU United Kingdom.
  4. Oxford Project to Investigate Memory and Ageing (OPTIMA) Nuffield Department of Clinical Neurosciences University of Oxford John Radcliffe Hospital Level 6 West Wing Oxford OX3 9DU United Kingdom.
  5. Oxford Parkinson's Disease Centre Department of Physiology Anatomy and Genetics University of Oxford Le Gros Clark Building, South Parks Road Oxford OX1 3QX United Kingdom.

PMID: 27752516 PMCID: PMC5048391 DOI: 10.1002/acn3.338

Abstract

We have developed a novel real-time quaking-induced conversion RT-QuIC-based assay to detect alpha-synuclein aggregation in brain and cerebrospinal fluid from dementia with Lewy bodies and Parkinson's disease patients. This assay can detect alpha-synuclein aggregation in Dementia with Lewy bodies and Parkinson's disease cerebrospinal fluid with sensitivities of 92% and 95%, respectively, and with an overall specificity of 100% when compared to Alzheimer and control cerebrospinal fluid. Patients with neuropathologically confirmed tauopathies (progressive supranuclear palsy; corticobasal degeneration) gave negative results. These results suggest that RT-QuiC analysis of cerebrospinal fluid is potentially useful for the early clinical assessment of patients with alpha-synucleinopathies.

References

  1. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4 - PubMed
  2. Acta Neuropathol Commun. 2015 Nov 26;3:75 - PubMed
  3. Lancet Neurol. 2013 May;12(5):443-53 - PubMed
  4. Ann Neurol. 2011 Mar;69(3):570-80 - PubMed
  5. Brain. 2016 Jan;139(Pt 1):47-53 - PubMed
  6. Parkinsonism Relat Disord. 2014 Jan;20(1):99-105 - PubMed
  7. Exp Neurol. 2008 Oct;213(2):315-25 - PubMed
  8. Mov Disord. 2003 Sep;18 Suppl 6:S21-7 - PubMed
  9. Genomics. 1995 May 20;27(2):379-81 - PubMed
  10. Acta Neuropathol. 2012 Jan;123(1):1-11 - PubMed
  11. Dement Geriatr Cogn Disord. 2008;26(4):343-50 - PubMed
  12. Eur J Neurosci. 2016 Jan;43(1):3-16 - PubMed
  13. Rev Neurol (Paris). 2015 Dec;171(12):812-24 - PubMed
  14. Arch Neurol. 1998 Nov;55(11):1449-55 - PubMed
  15. Brain. 2010 Mar;133(Pt 3):713-26 - PubMed
  16. Neurobiol Aging. 2015 Sep;36(9):2587-96 - PubMed
  17. Nat Rev Neurol. 2013 Jan;9(1):13-24 - PubMed
  18. Neurosci Lett. 2009 Feb 6;450(3):332-5 - PubMed

Publication Types

Grant support